Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression
Dahlhoff J, Manz H, Steinfatt T, Delgado-Tascon J, Seebacher E, Schneider T, Wilnit A, Mokhtari Z, Tabares P, Boeckle D, Rasche L, Kortuem KM, Lutz MB, Einsele H, Brandl A, Beilhack A (2022)
Publication Type: Journal article
Publication year: 2022
Journal
Book Volume: 36
Pages Range: 790-800
Journal Issue: 3
DOI: 10.1038/s41375-021-01422-y
Abstract
Multiple myeloma remains a largely incurable disease of clonally expanding malignant plasma cells. The bone marrow microenvironment harbors treatment-resistant myeloma cells, which eventually lead to disease relapse in patients. In the bone marrow, CD4+FoxP3+ regulatory T cells (Tregs) are highly abundant amongst CD4+ T cells providing an immune protective niche for different long-living cell populations, e.g., hematopoietic stem cells. Here, we addressed the functional role of Tregs in multiple myeloma dissemination to bone marrow compartments and disease progression. To investigate the immune regulation of multiple myeloma, we utilized syngeneic immunocompetent murine multiple myeloma models in two different genetic backgrounds. Analyzing the spatial immune architecture of multiple myeloma revealed that the bone marrow Tregs accumulated in the vicinity of malignant plasma cells and displayed an activated phenotype. In vivo Treg depletion prevented multiple myeloma dissemination in both models. Importantly, short-term in vivo depletion of Tregs in mice with established multiple myeloma evoked a potent CD8 T cell- and NK cell-mediated immune response resulting in complete and stable remission. Conclusively, this preclinical in-vivo study suggests that Tregs are an attractive target for the treatment of multiple myeloma.
Involved external institutions
Germany (DE)How to cite
APA:
Dahlhoff, J., Manz, H., Steinfatt, T., Delgado-Tascon, J., Seebacher, E., Schneider, T.,... Beilhack, A. (2022). Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression. Leukemia, 36(3), 790-800. https://doi.org/10.1038/s41375-021-01422-y
MLA:
Dahlhoff, Julia, et al. "Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression." Leukemia 36.3 (2022): 790-800.
BibTeX: Download